Patents
Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
04/2008
04/16/2008CN100381457C 8beta-vinil-11beta-(¿¿mega-substitu¿¼do)alquil-estra-1 ,3,5(10)-trienos
04/15/2008CA2509366C Process for the preparation of pregnanes
04/15/2008CA2358466C 17.beta.-acyl-17.alpha.-propynyl-11.beta.-arylsteroids and their derivatives having agonist or antagonist hormonal properties
04/09/2008EP1906960A1 New combination 1
04/09/2008CN100379753C Intermediates for 16 beta -methyl steroids
04/09/2008CN100379423C Topical medicine composite containing cholinergic drug or calcium channel paralyser
04/02/2008CN100378116C High purity composition comprising (7a, 17a,)-17-hydroxy-7-methyl 19-nor-17-prege-5-(10)-en-20-yn-3-one
03/2008
03/27/2008US20080076744 Method for treating inflammatory conditions with progesterone or progesterone analogs
03/25/2008CA2295455C Process for the preparation of mometasone furoate
03/19/2008EP1898922A2 Improved drug or pharmaceutical compounds and a preparation thereof
03/19/2008CN101143885A Glucocorticoids derivative, preparation method and application thereof
03/18/2008US7345037 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase
03/12/2008CN101139379A Method for producing total-dissolution diene
03/05/2008CN100372864C Process for the preparation of 7-alpha-methylsteroids
02/2008
02/20/2008CN101125877A Method for preparing methylprednisolone acetate
02/20/2008CN101125876A Preparation technique for high-purity hydrocortisone
02/12/2008CA2416823C Antimycotic nail varnish composition
02/06/2008CN101119733A Method for reducing or avoiding adverse effect of steroid compound
02/05/2008CA2283597C Reduced cortisol conjugates
01/2008
01/31/2008WO2008012833A1 A process for the preparation of 16-dehydropregenolone acetate ( 16-dpa)
01/29/2008CA2436540C Pharmaceutical compositions based on anticholinergics and corticosteroids
01/29/2008CA2093808C Methods, compositions, and compounds for allosteric modulation of the gaba receptor by members of the androstane and pregnane series
01/15/2008CA2123405C Angiostatic steroids
01/08/2008CA2450661C Preparation of flumethasone and its 17-carboxyl androsten analogue
01/08/2008CA2196690C Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
12/2007
12/27/2007US20070298456 Microbiological process for the production of 7-substitued 11-hydroxy steroids, 7,17-substituted 11-halogen steroids, and uses thereof
12/26/2007CN100357309C Carbon-21 steroidal glycosides possessing immunological suppression action
11/2007
11/06/2007US7291610 Estrogenic compounds as anti-mitotic agents
10/2007
10/10/2007CN101050229A Method for preparing hydrocortisone sodium succinate
09/2007
09/26/2007CN100339486C Microbiological method for the production of 7 alpha-substituted 11 alpha-hydroxysteroids
09/18/2007CA2236648C Sulfatation of estrogen mixtures
08/2007
08/30/2007US20070203106 Method for Producing 5Alpha-Pregnane Derivative
08/30/2007US20070203105 (11 beta ,16 alpha ,17 beta )-17-cyclopropylcarbonyl-16-methyl-11-[4-(3-pyridinyl)-phenyl]estra-4,9-dien-3-one; contraception; hormone replacement therapy; endometriosis, dysmenorrhea, dysfunctional uterine bleeding and severe premenstrual syndrome
08/28/2007US7262023 synthesis of steroids by hydroxylation and oxidation with use of microoganisms; biosynthesis
08/23/2007US20070197490 Method for producing 5alpha-pregnane derivative
08/23/2007US20070197489 Composition of matter
08/08/2007CN101012265A NO donor-type hydrocortisone derivative, its preparing method and antiphlogistic use
08/07/2007US7253156 E.g., budesonide dodecylcarbonate and budesonide 2-dimethylaminoethyl carbonatewith agonists such as albuterol, formoterol, or salmeterol; used for inducing bronchodilation and treating COPD, asthma and rhinitis.
07/2007
07/31/2007CA2223397C Novel nor-pregnanes for inducing hypothalamic effects
07/25/2007CN101003561A Polyhydroxyl steroid compound, synthetic method, and application
07/17/2007CA2158610C 17-deoxycorticosteroid-21-/o/-carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
07/05/2007US20070155781 ipratropium/flutropium/tiotropium derivatives; anticholinergic agent; linked at NO or NO2 group, or group which stimulates endogenous production of NO; beneficial therapeutic effects; asthma, respiratory disorder, cystic fibrosis; synergistic with NO release agent or substrate for nitric oxide synthase
07/03/2007CA2133607C Corticoid -17,21-dicarboxylic esters and corticosteroid 17-caboxylic esters 21-carbonic esters, processes for their preparation and pharmaceuticals containing these compounds
07/03/2007CA2130943C Corticosteroid 17-alkyl carbonate 21-[o]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds
06/2007
06/28/2007US20070149494 Method for producing 5alpha-pregnane derivative
06/27/2007CN1988886A Heat sterilization of glucocorticosteroids
06/20/2007CN1981761A Methods and compositions using immune regulative compound for treatment and management of cancers and other diseases
06/13/2007CN1978457A Method for producing 6 alpha-methylprednisolone and its derivatives
06/07/2007US20070129332 Processes to prepare eplerenone
05/2007
05/31/2007US20070123704 7alpha-biscarbonyl-substituted steroid compounds
05/24/2007US20070117780 Process to Prepare Eplerenone
05/22/2007CA2276694C New fatty acid derivatives
05/16/2007CN1315864C Oxidation process for preparing the intermediate 6alpha, 9alpha-difluoro-11beta, 17alpha-dihydroxy-16.alpha-methyl-androst-1, 4-dien-3-one-17beta-carboxylic acid
05/08/2007US7214672 Preventives/remedies for inflammatory airway diseases
04/2007
04/25/2007EP1599233B1 Sterilization of beclomethasone drug particles for pulmonary delivery
04/19/2007WO2007004236A3 Improved drug or pharmaceutical compounds and a preparation thereof
04/18/2007CN1948330A Preparation method of 1,4-dipregnene-16-beta-methyl-17-alpha-21-bihydroxy object
04/12/2007US20070082876 Novel C18 modified retrosteroids as progesterone receptor modulator compounds
04/04/2007CN1307971C Antimycotic nail varnish composition
03/2007
03/28/2007EP1767540A1 Method for producing 5 alpha-pregnane derivative
03/28/2007CN1938331A Method for producing 5 alpha-pregnane derivative
03/28/2007CN1938330A Method for producing 5 alpha-pregnane derivative
03/21/2007CN1934124A Method for producing 5alpha-pregnane derivative
03/21/2007CN1931870A Synthesis process of methyl prednisolone aceponate
03/15/2007US20070060555 antiinflammatory agent, antihistamines, immunosuppressant; docosapentaenoic acid ester glucocorticoid; rhinitis, asthma, chronic obstructive pulmonary disease; inhalation; local or topical administration
03/08/2007WO2007026651A1 Therapeutic agent for hypertension
03/08/2007CA2620553A1 Therapeutic agent for hypertension
03/07/2007CN1923841A 7 alpha-substituted 11 alpha-hydroxysteroids and its microbiological production method
03/06/2007US7186708 Steroidal compounds
03/06/2007CA2277913C New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
02/2007
02/28/2007EP1755554A2 Heat sterilization of glucocorticosteroids
02/27/2007CA2425849C Angiostatic steroids
01/2007
01/18/2007WO2007008155A1 New combination 1
01/17/2007EP1743902A1 Method for producing 5alpha-pregnane derivative
01/11/2007CA2613875A1 Improved drug or pharmaceutical compounds and a preparation thereof
01/10/2007EP1392320B1 17-METHYLENE-ANDROSTAN-3a-OL ANALOGS AS CRH INHIBITORS
01/09/2007US7160920 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
01/02/2007CA2168850C Estrogenic compounds as anti-mitotic agents
12/2006
12/19/2006CA2149496C 11,21-bisphenyl-19-norpregnane derivatives
12/13/2006EP1731526A1 Method for producing 5 alpha-pregnane derivative
12/07/2006US20060276443 21-substituted progesterone derivatives as new antiprogestational agents
11/2006
11/15/2006CN1863814A Process for the preparation of 7-alpha-methylsteroids
11/09/2006US20060252926 Process for the preparation of pregnanes
11/07/2006CA2281755C Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/02/2006US20060247452 Method for obtaining 17sg(a)-acetoxy-11$g(b)-(4-n,n-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
11/02/2006US20060247434 Method for the preparation of 6-alpha fluoro corticosteroids
10/2006
10/04/2006EP1422235B1 Stereoselective method of producing 6alpha-fluoropregnanes and intermediaries
09/2006
09/19/2006US7109187 Estrogenic compounds as anti-mitotic agents
09/13/2006CN1830991A 16 alpha-bromosteroid compound and its synthesis method
09/12/2006US7105637 Kits for detection/diagnosis of Smith-Lemli-Optiz syndrome
08/2006
08/30/2006CN1271993C New formulation for inhalation having a poured bulk density of from 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
08/29/2006US7098328 Method for the preparation of 6α-fluoro corticosteroids
08/24/2006WO2006088134A1 Method of relieving or avoiding side effect of steroid compound
08/23/2006CN1821263A Intermediates for 16 beta -methyl steroids
08/17/2006US20060183727 Estrogenic compounds as anti-mitotic agents
08/08/2006US7087591 21-substituted progesterone derivatives as new antiprogestational agents
08/03/2006US20060173201 Process for the produciton of tibolone
08/02/2006CN1810824A Momertasone furoate intermediate 21-ester and its prepn
07/2006
07/27/2006US20060166956 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration
07/27/2006US20060166955 Production process for 16-dehydropregnenoneol and its analogs
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 ... 20